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Introduction
The extracellular matrix controls tissue integrity, function, and 
differentiation (Rozario and DeSimone, 2010). The proteins and 
proteoglycans in the extracellular matrix depend largely on the 
tissue (Manabe et al., 2008). Several matrix proteins, such as 
fibronectin, laminins, or collagens, mediate cell adhesion and 
support cell differentiation. In addition to the role of its various 
components in interacting with cells, the physical properties of the 
extracellular matrix are of paramount importance in defining cell 
fate and behavior. For instance, human mesenchymal stem cells 
(hMSCs) cultured on the matrix of various degrees of stiffness 
undergo different cell fates so that a compliant matrix drives cells 
to become neuronal-like, whereas stiffer surfaces trigger differen-
tiation of the hMSC into osteoblasts (Engler et al., 2006). Finally, 
the extracellular matrix acts as a reservoir for signaling molecules 
(Hynes, 2009); this function appears to be particularly important 
for bone tissue (Ramirez and Rifkin, 2009). Thus, signaling pro-
teins, such as the bone morphogenetic proteins (BMPs) or FGFs, 
are sequestered by the extracellular matrix in active conforma-
tions (Dallas et al., 2005; Fontana et al., 2005). Such sequestration 
appears to be crucial not only during development but also to   
coordinate bone resorption and deposition (Matsuo, 2009).
Integrins are the main class of receptors implicated in 
cell–extracellular matrix interactions (Hynes, 1992). These re-
ceptors trigger cell adhesion and transmit outside-in and inside-
out  signals  and,  thereby,  are  involved  in  numerous  cellular 
functions, such as proliferation, apoptosis, cell fate decision, 
and extracellular matrix organization (Giancotti and Ruoslahti, 
1999). One of the most obvious functions of the extracellular 
matrix and of cell adhesion receptors is to control developmental 
T
he  morphogenetic  and  differentiation  events  re-
quired for bone formation are orchestrated by dif-
fusible and insoluble factors that are localized within 
the extracellular matrix. In mice, the deletion of ICAP-1, 
a  modulator  of  1  integrin  activation,  leads  to  severe   
defects  in  osteoblast  proliferation,  differentiation,  and 
mineralization  and  to  a  delay  in  bone  formation.  De-
position of fibronectin and maturation of fibrillar adhe-
sions,  adhesive  structures  that  accompany  fibronectin   
deposition, are impaired upon ICAP-1 loss, as are type I 
collagen deposition and mineralization. Expression of   
1 integrin with a mutated binding site for ICAP-1 re-
capitulates the ICAP-1–null phenotype. Follow-up ex-
periments demonstrated that ICAP-1 negatively regulates 
kindlin-2  recruitment  onto  the  1  integrin  cytoplasmic 
domain, whereas an excess of kindlin-2 binding has a 
deleterious effect on fibrillar adhesion formation. These 
results suggest that ICAP-1 works in concert with kindlin-2 
to control the dynamics of 1 integrin–containing fibrillar 
adhesions and, thereby, regulates fibronectin deposition 
and osteoblast mineralization.
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(Bouvard et al., 2007). Because ICAP-1 interacts with 1 in-
tegrin (Chang et al., 1997; Zhang and Hemler, 1999; Bouvard 
et al., 2003) and despite the contradictory data concerning   
1 integrins and bone formation described in the Introduction, 
we examined the roles of 1 integrins and a major ligand, fibro-
nectin, in osteoblast function. Primary osteoblasts from 1
fl/fl 
or Fn
fl/fl mice were immortalized, and the gene of interest was 
deleted by viral transduction with Cre recombinase. Deletion 
was confirmed by immunostaining and FACS analysis for 
1 integrin (Fig. S1) and by Western blotting for fibronectin   
(Fig. S2 C). The resulting cell lines retained their ability to dif-
ferentiate into osteoblasts, and the following results were con-
firmed for at least two separate lines of each (Chiba et al., 1993; 
Bouvard et al., 2007).
Inasmuch as osteoblast condensation occurs during early 
differentiation, we asked whether 1 integrins were required in 
this process (Hall and Miyake, 2000), especially because ICAP-1 
loss leads to abnormal compaction at 24 h (Fig. 1 A; Bouvard   
et al., 2007). 1
/ cells were unable to form spheroids, in con-
trast to wild-type or rescue cells (Fig. 1 B), and instead, they 
formed only small aggregates, presumably because of the pres-
ence of cadherins that mediated cell–cell adhesions (Stains and 
Civitelli, 2005). Because 51 integrin has been shown to be 
critical for fibronectin deposition and organization (Hynes et al., 
1992), we therefore examined whether the defect in osteoblast 
compaction could result from a defect in fibronectin deposition. 
For this purpose, we analyzed osteoblasts lacking fibronectin. 
These fibronectin-null cells were unable to form spheroids, in 
contrast to the wild type (Fig. 1 C). Thus, cell compaction re-
quires both 1 integrins and their extracellular ligand fibronec-
tin. Fibronectin might either activate specific signals or provide 
an extracellular scaffold that allows cell compaction. To distin-
guish  these  two  possibilities,  we  used  a  49-residue  peptide 
called functional upstream domain (FUD) that has been shown 
to bind to multiple N-terminal type I modules of fibronectin 
and, thereby, inhibit assembly of fibronectin into an insoluble 
matrix  (Ensenberger  et  al.,  2001,  2004; Tomasini-Johansson   
et al., 2001; Zhou et al., 2008; Maurer et al., 2010). Treating the 
osteoblasts with FUD resulted in abnormal compaction, sug-
gesting that fibronectin deposition is required for compaction to 
proceed normally (Fig. 1 C). FUD treatment neither alters cell 
shape nor proliferation, and therefore, adhesion mediated by   
1 integrins was presumably not affected (Fig. S2). To confirm the 
key role of fibronectin fibrillogenesis in mediating 1 integrin 
effects on osteoblast compaction, we inhibited fibrillogenesis by 
using a Rho-associated kinase (ROCK) inhibitor. RhoA/ROCK 
act downstream of 51 and mediate cell contractility required 
during compaction and for fibronectin fibrillogenesis (Zhong   
et al., 1998; Yoneda et al., 2007). Confirming previous data, the 
inhibition of ROCK reduced the insoluble fraction of fibronec-
tin and hence the deposition of fibronectin in the extracellular 
matrix (Fig. 1 D; Schwarzbauer, 1991; Zhong et al., 1998). ROCK 
inhibition also reduced osteoblast compaction (Fig. 1 D). It has 
been proposed that ICAP-1 might be involved in ROCK mem-
brane targeting in myoblasts (Stroeken et al., 2006). We there-
fore  wondered  whether  the  effect  of  ICAP-1  on  osteoblast 
compaction could be caused by inefficient ROCK signaling. 
processes. Indeed, the importance of various integrin family 
members for tissue-specific development or function has been 
unraveled by the use of genetically modified mice in which spe-
cific integrins have been targeted (Bouvard et al., 2001).
Bones are formed by the close interplay between osteo-
blasts, which are bone matrix–depositing cells, and osteoclasts, 
which are bone-resorbing cells. The precise function of the differ-
ent integrins in bone homeostasis is rather puzzling, inasmuch as 
data reported on osteoblasts are contradictory. Although some 
in vitro data strongly suggest that 1 integrins are critical for 
osteoblast differentiation and function, the role of 1 integrins 
in vivo is less clear (Moursi et al., 1996; Xiao et al., 1998; Wang 
et al., 2006; Hamidouche et al., 2009). Cell type–specific Cre-
mediated deletion of 1 integrin in the osteoblast lineage directed 
by the 2.3-kb type I collagen promoter leads to minor develop-
mental and functional defects resulting from a defect in mecha-
notransduction in the osteocytes (Phillips et al., 2008). The minor 
phenotype suggests either an important compensatory effect from 
other integrins, such as v forming heterodimers with other   
 subunits, or/and an early role of 1 integrins that was not revealed 
because of its late deletion. Similarly, the expression of a domi-
nant-negative form of 1 integrin in mature osteoblasts shows 
only mild effects on bone formation (Zimmerman et al., 2000).
The mild effects of targeting 1 integrin in late osteo-
blast lineage contrast with the phenotypic analysis of Icap-1  
(Itgb1bp1
tm1Ref)–deficient mice. ICAP-1 is a small protein that 
interacts in a specific manner with the 1A integrin cytoplasmic 
domain (Chang et al., 1997; Zhang and Hemler, 1999). It nega-
tively  regulates  talin  binding  onto  1  integrin  and,  thereby, 
would be expected to limit integrin activation (Bouvard et al., 
2003, 2006, 2007; Millon-Frémillon et al., 2008). Germline de-
letion of Icap-1 in a mouse impairs osteoblast differentiation 
and proliferation in vitro and in vivo. Icap-1–deficient osteo-
blasts display defects of adhesion, compaction, and migration 
(Bouvard et al., 2007; Millon-Frémillon et al., 2008), which ex-
plains, at least partly, the bone phenotype observed in vivo.
In this paper, we provide a molecular explanation of how 
ICAP-1, likely by direct binding onto 1 integrin, affects osteo-
blast function. We show that fibronectin assembly is controlled 
by the binding of ICAP-1 to the 1 integrin tail and that such 
binding is required for bone mineralization. Our results reveal 
the critical role of ICAP-1 in modulating the dynamics of fibril-
lar adhesions, which are adhesive structures responsible for   
fibronectin deposition. We demonstrate that the control of matrix 
assembly by ICAP-1–1 integrin interaction plays an important 
role in governing essential developmental events, such as osteo-
blast  mineralization. We  also  provide  evidence  that  ICAP-1 
negatively regulates recruitment of kindlin-2 onto the 1 integ-
rin cytoplasmic domain and that an excess of kindlin-2 binding 
has a deleterious effect on fibrillar adhesion formation.
Results
Osteoblast cell compaction depends on 
fibronectin organization
We  previously  demonstrated  that  in  vitro  bone  nodule   
formation is defective in the absence of the ICAP-1 protein 309 ICAP-1 regulates osteoblast mineralization • Brunner et al.
Figure 1.  Cell matrix interaction and contractility are required for osteo-
blast compaction. (A) Cellular compaction of Icap-1
+/+ (wild type), Icap-1
WT 
(rescue), and Icap-1
/ osteoblasts after 24 or 48 h. (B) Cellular compac-
tion of 1
fl/fl (wild type), 1
WT (rescue), and 1
/ osteoblasts after 24 h. 
(C) Cellular compaction after 24 h of Fn
/ osteoblasts and Fn
fl/fl (wild type) 
treated or not treated with 100 ng/ml FUD. (D) ROCK and ICAP-1 additive 
control of cell compaction and fibronectin deposition. (top) Fibronectin dep-
osition was monitored in Icap-1
+/+ (wild type) and Icap-1
/ osteoblasts 
treated with DMSO (control) or ROCK inhibitor (Y27632). (left) Fibronectin 
amounts (Fn) were estimated by Western blotting, and the protein load was 
normalized using actin (Act). (right) Quantification of fibronectin deposi-
tion shown as the means and SDs from three independent experiments 
using ImageJ software. (bottom) Cell compaction of Icap-1
+/+ (wild type) 
and Icap-1
/ in presence of DMSO (control) or ROCK inhibitor (Y27632) 
were imaged after 24 h. Sol, soluble; Insol, insoluble. Bars, 1 mm.
Icap-1–deficient cells were treated with the ROCK inhibitor 
Y27632, and both fibronectin deposition and cell compaction 
were analyzed. As shown in Fig. 1 D, inhibition of ROCK in 
Icap-1–deficient cells further blocked fibronectin assembly rela-
tive to ROCK inhibition alone or to ICAP-1–deficient cells, which 
shows an additive effect. This finding suggests that ROCK and 
ICAP-1 do not belong to the same linear signaling pathway but 
rather to separate pathways. In summary, our data show that   
1 integrin, ICAP-1, and fibronectin are required for osteoblast 
compaction and suggest that 1 integrin effects on compaction 
are mediated by its ability to modulate fibronectin assembly.
Icap-1 loss reduces fibronectin deposition
The nodule formation assays for osteoblast function were per-
formed in 3D cultures. To determine whether a fibronectin defect 
could be extended to 2D cultures that would be suited for multi-
probe fluorescence microscopy, the experiments were repeated 
using cells seeded on plates. We investigated whether matrix-
associated fibronectin deposition could be perturbed by the loss 
of ICAP-1. Indeed, both wild-type and rescue cells displayed a 
larger fraction of matrix-associated insoluble fibronectin than 
Icap-1–null osteoblasts (insoluble to soluble ratio in control 
cells: 1.3 ± 0.2 vs. 0.7 ± 0.2 in Icap-1–deficient cells; P < 0.001; 
Fig. 2, A and B). Immunolabeling of fibronectin on cultured 
cells showed that most of the cells in Icap-1–null cultures were 
associated with punctate deposits of fibronectin, whereas most 
of the ICAP-1–expressing cells were associated with dense de-
posits of fibronectin (Fig. 2 C). Similar results were obtained on 
spheroids cultures, showing that the fibronectin fibrillogene-
sis defect was not restricted to 2D culture conditions (Fig. S3, 
A–C). Importantly, there was no reduction in fibronectin ex-
pression and secretion in Icap-1–deficient cells as measured 
by quantitative PCR and Western blotting. Indeed, fibronectin 
mRNA expression and fibronectin secreted to medium were 
increased when ICAP-1 was lost (Fig. S3 D). Thus, the defect 
in fibronectin assembly observed in Icap-1–null cells was not 
caused by a decrease in fibronectin expression or secretion.
Direct 1 integrin–Icap-1 interaction 
controls fibronectin assembly  
by osteoblasts
We previously reported that ICAP-1 regulates 1 integrin func-
tion by reducing its affinity, likely by impairing talin recruit-
ment (Bouvard et al., 2003; Millon-Frémillon et al., 2008). 
To determine whether ICAP-1–mediated down-regulation of   
1 integrin affinity is involved in fibronectin fibrillogenesis, we 
generated various point mutations in the human 1 integrin cyto-
plasmic domain that have been reported to interfere with spe-
cific functions. One of those is the mutation at valine 787, which 
is important for ICAP-1 binding on 1 integrin (Chang et al., 
2002). To minimize a potential side effect of this mutation on 
the recruitment of other molecules, such as kindlins, we gener-
ated a mutated 1 in which valine 787 was replaced by a threo-
nine. This point mutation mimics the membrane-distal part of the 
2 integrin cytoplasmic tail that does not bind ICAP-1 despite 
its high similarity with 1 integrin while still binding other pro-
teins, such as kindlins (Chang et al., 2002; Moser et al., 2009). JCB • VOLUME 194 • NUMBER 2 • 2011   310
deposition significantly (Fig. 3). Next, we wondered whether 
the fibronectin fibrillogenesis defect observed in Icap-1–null 
cells  was  associated  with  altered  fibronectin  reorganization. 
Wild-type, rescue, and Icap-1–null osteoblasts were seeded on 
a fibronectin coat, cultured for 3 h, fixed, and double stained for 
fibronectin and 1 integrin to visualize the capability of the 
cells to reorganize the surrounding extracellular matrix (Fig. 4). 
Whereas wild-type and rescue cells reorganized the fibronectin 
coating into fibrils that partially co-distributed with fibrillar   
arrays of 1 integrins, only minimal redistribution of fibronec-
tin or fibrillar arrays of integrins were observed with Icap-1–
null osteoblasts (Fig. 4 A). Treatment of wild-type cells with the 
FUD peptide also blocked fibronectin redistribution in this   
assay (Fig. 4 B). These findings suggest that ICAP-1 controls 
fibrillar adhesion dynamics, which in turn, leads to fibronectin 
matrix reorganization.
Fibrillar adhesion dynamics are impaired  
in Icap-1–null cells
Based on the evidence that ICAP-1 is likely required for fibro-
nectin fibrillogenesis via its direct binding onto 1 integrin 
The V787T mutation resulted in decreased ICAP-1 binding to 
1 integrin without interfering with the binding of kindlin-2 
and talin head (Fig. S4). The 1
V787T integrin mutant was intro-
duced into 1-null osteoblasts, and positive cells were selected 
by FACS based on human 1 expression (Fig. S1 A). Compared 
with control cells, osteoblasts expressing the 1
V787T integrin 
showed a significant decrease in insoluble matrix-bound fibro-
nectin (Fig. 3, A and B). In line with this observation, fibronec-
tin immunofluorescent staining in confluent cultures of 1
V787T 
cells revealed less fibronectin deposition than in control cells 
(Fig. 3 C). Altogether, the defect in fibronectin fibrillogenesis 
observed in both Icap-1–null cells and 1
V787T cells strongly 
suggests that efficient fibronectin fibrillogenesis requires the di-
rect binding of ICAP-1 onto the 1 integrin cytoplasmic tail.
The introduction of D759A point mutation into 1 inte-
grin (known to trigger a preactivation state; Hughes et al., 1996; 
Sakai et al., 1998) reproduced the effect of the lack of ICAP-1 
on focal adhesion dynamics (Millon-Frémillon et al., 2008). We 
therefore asked whether this mutation also alters fibronectin 
fibrillogenesis.  In  line  with  previous  results  with  fibroblasts 
(Sakai et al., 1998), 1
D759A osteoblasts did not reduce fibronectin 
Figure 2.  Icap-1
/ osteoblasts in 2D culture exhibit a defect in fibronectin deposition. (A) Icap-1
+/+ (wild type), Icap-1
WT (rescue), and Icap-1
/ cells 
were cultured for 3 d and then lysed in a buffer containing deoxycholate to separate the insoluble matrix-bound fibronectin (Insol) from the soluble fibro-
nectin (Sol). Fibronectin (Fn) amounts were estimated by Western blotting, and the protein load was normalized using actin (Act). (B) Quantification of 
10 independent experiments using ImageJ software. Quantifications are shown as the means and SDs of the ratio of insoluble/soluble fibronectin frac-
tion (a single and a double asterisk show a significant difference with P = 0.001 and 0.0004, respectively; NS, no significant difference with P = 0.3).   
(C) Fibronectin deposition of Icap-1
/, Icap-1
WT (rescue), and Icap-1
+/+ (wild type) cells in 2D culture. Cells were fixed and immunostained for fibronectin 
and counterstained with DAPI. Bar, 20 µm.311 ICAP-1 regulates osteoblast mineralization • Brunner et al.
of tensin to focal and fibrillar adhesions to follow its translo-
cation from one structure to another. Both control and Icap-1– 
deficient cells were seeded on fibronectin-coated glass coverslips 
in the absence of serum, resulting in tensin localization at pe-
ripheral focal adhesions (Fig. 6 A).
[ID]FIG6[/ID] After 1 h of adhesion, the 
serum-free medium was replaced by serum-containing complete 
medium to increase cell contractility and enable fibronectin 
fibrillogenesis (Zhang et al., 1994). After 4 h, the cells were 
fixed, and mRFP fluorescence was analyzed to localize tensin. 
As shown in Fig. 6 A, at time 0, tensin was concentrated at the 
cell periphery in all genotypes. After addition of complete me-
dium to wild-type and rescue cells, tensin moved centrally, con-
versely to Icap-1–null cells in which tensin remained at the cell 
edges (Fig. 6 A). The apparent perturbation of tensin dynamics 
upon ICAP-1 loss was confirmed using time-lapse video mi-
croscopy of wild-type and Icap-1–null cells expressing mRFP-
tensin that were seeded on glass coverslips in complete medium 
(Fig. 6 B). As expected, in wild-type cells, time course analysis 
of mRFP-tensin localization showed translocation from the cell   
edge to cell center (Zamir et al., 1999). In contrast, in Icap-1–null 
osteoblasts, tensin translocation was not directionally oriented 
toward the cell center, but rather the protein kept a static localiza-
tion (Fig. 6 B). This defect in fibrillar adhesion formation was 
further confirmed using a 1 integrin antibody in the pulse-chase 
experiment (Fig. S5; Pankov et al., 2000). Although control 
cells displayed clear 1 integrin translocation from peripheral 
focal adhesions sites to fibrillar adhesions, Icap-1–deficient cells 
and modulation of movement of 1 integrins into fibrillar ad-
hesions, we further analyzed the molecular organization of 
adhesive structures. Thus, we immunostained cultured cells for 
fibronectin, talin, and 1 (Fig. 5). As shown in previous experi-
ments,  Icap-1–deficient  osteoblasts  exhibited  reduced  stain-
ing for fibronectin (Fig. 5 A). Talin staining in wild-type and 
Icap-1–null cells was located at the periphery of both cells but 
in thinner and more elongated streaks in mutant cells than in 
control cells (Fig. 5 B). Thus, in wild-type cells, talin appears 
to preferentially remain within focal adhesions rather than fol-
lowing fibrillar adhesions. When talin and 1 integrin were 
costained in wild-type cells, talin was concentrated at the cell 
periphery, whereas 1 integrin displayed a different distribu-
tion pattern with extended streaks originating from the cell edge 
and pointing to the cell center. Costaining of Icap-1–null cells 
demonstrated colocalization of talin and 1 integrin through-
out the length of the streaks. Image analysis corroborated that   
talin and 1 integrin distribution patterns were different in 
Icap-1–null and wild-type cells (Fig. 5 C). Thus, in Icap-1– 
deficient cells, talin and 1 integrin colocalized in adhesive 
structures, suggesting that 1 integrins are not translocated nor-
mally into fibrillar adhesions, or fibrillar adhesion formation is 
somehow otherwise impaired.
To analyze fibrillar adhesion dynamics further, we gener-
ated Icap-1–deficient and wild-type cells expressing monomeric 
RFP (mRFP)–tagged tensin, a marker of fibrillar adhesions   
(Zamir et al., 1999). We took advantage of the dual localization   
Figure 3.  Fibronectin fibrillogenesis requires 1 integrin in an ICAP-1–dependent manner. (A) 1
fl/fl (wild type), 1
WT (rescue), 1
D759A, 1
/, and 
1
V787T cells were cultured for 3 d and then lysed in a buffer containing deoxycholate to separate the insoluble matrix-bound fibronectin (Insol) from the 
soluble fibronectin (Sol). Fibronectin (Fn) amounts were estimated by Western blotting, and the protein load was normalized using actin (Act). (B) Quantifica-
tion of four independent experiments using ImageJ software. Quantifications are shown as means and SDs of ratio of insoluble/soluble fibronectin fraction   
(a  double  and  single  asterisk  shows  a  significant  difference  with  P  =  0.001  and  0.015,  respectively;  NS,  no  significant  difference  with  a  P  =  0.18).   
(C) 1
WT (rescue), 1
fl/fl (wild type), 1
D759A, 1
/, and 1
V787T cells were fixed and immunostained for fibronectin and counterstained with DAPI. Bar, 10 µm.JCB • VOLUME 194 • NUMBER 2 • 2011   312
a greater localization at focal adhesion sites (unpublished data). 
This observation suggested that ICAP-1 negatively regulates 
kindlin-2 localization within focal adhesions. To address the 
role of ICAP-1 in regulating kindlin-2 binding on 1 integrin 
cytoplasmic domain more directly, we expressed ICAP-1 in 
HEK 293 cells and analyzed whether ICAP-1 modulates the 
interaction of kindlin-2 with the GST-1 fusion protein in a 
pull-down assay. ICAP-1 overexpression significantly reduced 
the amount of kindlin-2 in GST-1 pull-down assays, again 
arguing that ICAP-1 negatively regulates kindlin-2 binding on 
1 integrin (Fig. 7 B).
To explore whether part of the Icap-1–null phenotype is 
caused by an excess of kindlin-2 binding onto 1 integrin, we 
selected an osteoblast cell line in which kindlin-2 expression 
was maximal (Fig. S4) and used it to see whether fibronectin   
fibrillogenesis proceeded correctly. Such overexpression of 
kindlin-2 dramatically reduced fibronectin deposition, relative 
to nontransfected cells (Fig. 7 C).
Matrix-associated fibronectin controls 
osteoblast mineralization
We previously reported that Icap-1–null mice exhibit decreased 
osteoblast proliferation, differentiation, and mineralization, result-
ing in a distinct bone phenotype (Bouvard et al., 2007). On the   
other hand, fibronectin has been shown to be crucial for osteo-
blast differentiation and survival in vitro and in vivo (Moursi   
et al., 1996, 1997; Bentmann et al., 2010). We therefore examined 
displayed only faint 1 staining close to the cell edge, suggest-
ing a profound perturbation of 1 dynamics. These results all 
indicate that ICAP-1 has an important role in the dynamics of 
fibrillar adhesions and provide a reasonable explanation for the   
fibronectin deposition defect observed in Icap-1–deficient cells.
Icap-1 regulates recruitment of kindlin-2 on 
the 1 integrin cytoplasmic domain
ICAP-1 and kindlins interact with an overlapping binding site 
on the cytoplasmic domain of 1 integrin (Chang et al., 1997; 
Zhang and Hemler, 1999; Larjava et al., 2008; Ma et al., 2008; 
Montanez  et  al.,  2008;  Meves  et  al.,  2009). Therefore,  we 
addressed the potential effect of ICAP-1 in the regulation of 
kindlin-2 binding on 1 integrin. First, we made use of Icap-1– 
deficient cells and the 1
V787T integrin mutant to analyze whether 
loss of ICAP-1 binding on 1 integrin could affect kindlin-2 
localization. 1
fl/fl, Icap-1
/, and 1
V787T were transduced 
with EGFP–kindlin-2 retrovirus to generate cell lines. Based 
on EGFP expression, clones were selected for their expression 
level (Fig. S4 and not depicted). Interestingly, high expression 
of EGFP–kindlin-2 was achieved readily in control cells but 
always low in Icap-1–deficient cells as well as in 1
V787T mutant 
cells, already suggesting a molecular interaction. Kindlin-2 
localization in focal adhesions was easily detectable in 1
V787T 
and  Icap-1–deficient  cells,  whereas  control  cells  displayed 
faint staining, mainly at the cell edge (Fig. 7 A). Increasing 
the expression of kindlin-2 in control cells was associated with   
Figure 4.  Fibronectin reorganization depends on Icap-1 and its ability to self-assemble. (A) Icap-1
+/+ (wild type), Icap-1
WT (rescue), and Icap-1
/ cells 
were seeded on fibronectin-coated coverslips. After 4 h of incubation, cells were fixed and immunostained for 1 integrin (green) and for total fibronectin 
(red). (B) Wild-type cells were seeded on fibronectin in the absence or presence of FUD (Icap-1
+/+ +FUD). After 4 h of incubation, cells were fixed and 
immunostained for 1 integrin (green) and for total fibronectin (red). Bars, 10 µm.313 ICAP-1 regulates osteoblast mineralization • Brunner et al.
at day 20 (Fig. 8, arrowheads). We also observed mineralization 
with the 1
D759A mutant (Fig. 8, arrowheads), which agrees with 
the fact that this point mutation does not impair fibronectin de-
position (Fig. 3). Although the color uptake varied depending on 
the speed of mineralization, we constantly observed bone nodules 
when osteoblasts expressing 1
fl/fl (rescue), 1
WT, and 1
D759A 
were used, in sharp contrast to osteoblasts expressing 1
/ and 
whether the mineralization defect of Icap-1–null osteoblasts might 
be caused by the aforementioned defect in fibronectin fibrillogen-
esis. For this, we monitored the in vitro mineralization capabilities 
of osteoblasts expressing 1
fl/fl (wild type), 1
/, 1
WT (rescue), 
1
D759A, and 1
V787T. As expected, the induction of differentiation 
of wild-type and rescue 1 osteoblasts resulted in the appearance 
of mineralized bone nodules, revealed by Alizarin red S staining 
Figure 5.  Fibrillar adhesion formation is defective in Icap-1
/ osteoblasts. (A) Icap-1
+/+ (wild type) or Icap-1
/ osteoblasts were seeded on fibronectin-
coated coverslips in complete medium. After overnight incubation, the cells were fixed and immunostained for talin and fibronectin (Fn) and counterstained 
with DAPI (blue). (B) Immunostaining of talin (red) and 1 integrin (green) counterstained with DAPI (blue) of Icap-1
+/+ (wild type) or Icap-1
/ osteoblasts. 
A typical area used for pixel plot analysis is boxed. (C) Pixel intensity profile along focal adhesion for talin and 1 integrin is represented from cell edge 
to cell center. These plots are representative of ≥10 different plots analyzed. Bars, 10 µm.JCB • VOLUME 194 • NUMBER 2 • 2011   314
Figure 6.  Tensin dynamics are impaired in Icap-1
/ osteoblasts. (A) Localization of mRFP-tensin in Icap-1
+/+ (wild type), Icap-1
WT (rescue), and Icap-1
/ 
cells in the absence (T = 0 h) or presence (T = 4 h) of serum. Arrows indicate peripheral focal adhesions; the arrowhead indicates dorsal fibrillar adhe-
sions. (B) Time-lapse video microscopy of mRFP-tensin in Icap-1
+/+ (wild type) and Icap-1
/ osteoblasts seeded on glass coverslips. Frames at time 0, 30, 
and 300 min were extracted from a representative video and arbitrarily colored in green, red, and blue. The boxed areas in the top images are shown 
at higher magnifications below. Bars, 10 µm.315 ICAP-1 regulates osteoblast mineralization • Brunner et al.
Figure 7.  ICAP-1 regulates fibrillogenesis by negatively regulating kindlin-2 binding on 1 integrin. (A) EGFP–kindlin-2 localization in wild-type, 1
V787T, 
or Icap-1
/ cells seeded overnight on glass coverslips. (B) Kindlin-2 binding on 1 integrin in the presence of a normal (mock) or high level of ICAP-1 
(Icap-1) was analyzed using pull-down assays. Kindlin-2 binding on GST alone, GST-1, and GST-3 as well as ICAP-1 expression was visualized by 
Western blotting, and kindlin-2 bindings to GST-1 (blue) and GST-3 (green) were quantified using ImageJ software and shown as the means and SDs of 
six independent experiments (asterisk indicates a significant difference with P = 0.05). (C) Visualization of fibronectin (Fn) deposition in cells expressing 
different levels of EGFP–kindlin-2 (from nontransfected cells [mock], moderate [medium], and high level [high]). Fibronectin deposition was visualized by 
immunofluorescence (top) or after biochemical fractionation to determine the relative quantity of matrix-bound fibronectin (insol) and the nonorganized 
counterparts (sol; bottom). Data are the means and SDs representatives of three different experiments performed with two different clones (the asterisk 
indicates a significant difference with P = 0.0009). Bars, 10 µm.JCB • VOLUME 194 • NUMBER 2 • 2011   316
1
V787T, which were unable to form mineralized bone nodules de-
spite their ability to express alkaline phosphatase, an early marker 
of osteoblast commitment (Fig. 8). Interestingly, osteoblasts ex-
pressing 1
/ and 1
V787T also displayed a fibronectin deposition 
defect, similar to that of Icap-1–null osteoblasts (Figs. 2 and 3). 
These observations suggest that fibronectin organization is cru-
cial for osteoblast mineralization. To test by a second approach 
whether fibronectin organization is required for proper mineral-
ization, we blocked fibronectin assembly in wild-type cells by 
FUD and followed mineralization. In contrast to untreated wild-
type cells, which displayed extensive mineralization, FUD-treated 
cells showed a significant reduction in mineralization (Fig. 9 A). 
Again, as we observed for cells with altered 1 integrin, the ex-
pression of alkaline phosphatase was still detectable, showing that 
treated cells have retained their capacity to commit to osteoblasts. 
Together, these data indicate that fibronectin organization is cru-
cial for osteoblast mineralization.
We next considered how fibronectin influences mineral-
ization and hypothesized that fibronectin directs deposition of 
other molecules to support mineralization. Because fibronectin 
directly binds to type I collagen and is important for its deposi-
tion, we immunostained for type I collagen control (wild type), 
Icap-1
/, or 1
/ osteoblasts during their differentiation 
(Fig. 9 B). In contrast to controls that clearly showed a significant 
and reproducible increase in collagen immunoreactivity after 
differentiation, Icap-1– as well as 1-deficient cells did not in-
crease their amount of type I collagen. Very similar results were 
obtained when control cells were treated with FUD (unpublished 
data). These results show that fibronectin is an important regu-
lator of type I collagen deposition by osteoblasts. To relate the 
lack of mineralization in cultures of mutant cells with the ab-
sence of a “mineralizable” matrix, we seeded control, Icap-1–, 
and 1-deficient cells in gels containing a high concentration 
of collagen. Induction of differentiation led to mineralization 
in  both  control  and  Icap-1–deficient  osteoblasts,  although 
to a much lower extent in Icap-1–null osteoblasts (Fig. 9 C).   
1 integrin–deficient osteoblasts also displayed mineralization 
but to a much lower extent than control cells, likely reflecting 
their profound defect in proliferation (Fig. 9 C). Therefore, by 
providing an appropriate matrix, Icap-1
/ cells were able to 
mineralize, demonstrating that in vitro, the absence of mineral-
ization is primarily caused by an altered matrix.
Because the effect of a lack of ICAP-1 on fibronectin dep-
osition could be reproduced by kindlin-2 overexpression, we 
asked whether this phenocopy could be extended to the miner-
alization defect. Indeed, overexpression of kindlin-2 strongly 
repressed  mineralization,  supporting  our  previous  findings   
(Fig. 9 D). Altogether, these data highlight a novel important 
function of ICAP-1 in regulating kindlin-2 recruitment on   
1 integrin and the subsequent extracellular matrix organization.
Discussion
Icap-1 regulates fibronectin assembly  
in a 1 integrin–dependent manner
The experiments described herein define a new role for ICAP-1 
in facilitating fibronectin fibrillogenesis. Our investigations   
explain why germline deletion of Icap-1 in mice impairs osteo-
blast differentiation and proliferation in vitro and in vivo and 
why Icap-1–deficient osteoblasts display defects of adhesion, 
compaction, and migration.
Building on our previous study demonstrating increased 
assembly of focal adhesions in the absence of ICAP-1 (Millon-
Frémillon et al., 2008), we show here that loss of ICAP-1 per-
turbs the maturation of focal adhesions into fibrillar adhesions. 
Interestingly, expressing preactivated integrin bearing mutation 
D759A reproduced the altered dynamics of focal adhesions 
seen in Icap-1–null cells but not the reduced fibronectin fibrillo-
genesis. Reconciling this apparent discrepancy calls for more 
extensive work, but it is likely that the transition of focal adhe-
sions to fibrillar adhesions requires cycling and/or recruitment 
of critical proteins. Supporting this view is the distribution of 
talin, which is more concentrated in focal adhesions than in 
fibrillar adhesions. Conversely, tensin is almost absent from focal 
adhesions (for cells cultured in complete medium) but enriched 
in fibrillar adhesions. Thus, one can easily envision that focal 
and fibrillar adhesion dynamics, formation, or initiation might 
be differentially regulated. In such a model, the importance of 
the salt bridge of  and 1 integrin cytoplasmic tails might be 
more important in one context than the other. Talin, which has 
been reported to disrupt the salt bridge (Anthis et al., 2009), is 
more concentrated in focal adhesions. The salt bridge disrup-
tion may be less important for the dynamics of fibrillar adhe-
sions, which contain little talin, and may be, instead, controlled 
by other tail–effector interactions. In any case, our findings are 
consistent with the absence of an obvious phenotype in a 
knockin mouse model expressing the D759A mutation (Czuchra 
et al., 2006).
The effect of ICAP-1 on the cell ability to assemble fibro-
nectin fibers was likely dependent on the direct interaction be-
tween ICAP-1 and the 1 integrin chain, as ascertained by the 
finding that expression of mutated 1 integrin with reduced 
ICAP-1 affinity recapitulates both defects: i.e., the lack of fibro-
nectin  assembly  and  mineralization  defect.  Furthermore,  we 
provide evidence that ICAP-1 plays an important role in regu-
lating the recruitment of 1 integrins to fibrillar adhesions and, 
thereby, the dynamics of fibrillar adhesions.
These results support the view that fibrillar adhesions and 
focal adhesions are distinct structures with specific composition 
and dynamics (Cukierman et al., 2001; Green et al., 2009). In 
addition, the two adhesion types support different functions of 
1 integrins: focal adhesions for cell adhesion and fibrillar adhe-
sions for deposition and organization of the extracellular matrix. 
How these structures are related is an open question. Locking   
integrin affinity would be expected to cause defects in spreading 
and migration mediated by focal adhesions or in extracellular 
matrix organization mediated by fibrillar adhesions. One inter-
esting observation is the segregation of 1 integrins in either focal 
adhesions or fibrillar adhesions depending on the cellular con-
text. We always observed formation of fibrillar adhesion sites 
when cells were cultured on an uncoated substrate. Conversely, 
forcing 1 integrin into focal adhesions by seeding cells on con-
centrated  fibronectin-coated  surfaces  or  blocking  fibronectin 
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that 1 integrin could be required at an early stage in focal adhe-
sion assembly before being engaged in fibrillar adhesions. This 
would explain why cells need 1 integrin activation for fibrillar 
adhesions to be formed (Green et al., 2009). Loss of ICAP-1 
increased focal adhesion formation. Our hypothesis is that   
either ICAP-1 loss or increase in kindlin-2 expression favors   
1 localization at focal adhesion sites and disfavors its recruit-
ment at fibrillar adhesions. However, this view does not rule out 
Figure 8.  1 integrin regulates in vitro mineralization in an Icap-1–dependent manner. 1
fl/fl (wild type), 1
WT (rescue), 1
D759A, 1
V787T, and 1
/ cells 
were induced to differentiate into osteoblasts. Expression of alkaline phosphatase (ALP) was used to follow the early commitment of cells to the osteoblast 
lineage at day 0 (D0) and day 15 (D15). Mineralization was visualized by Alizarin red S staining (ARS) at day 20 (D20). Arrowheads indicate mineral-
ized bone nodules. Bar, 1 mm.JCB • VOLUME 194 • NUMBER 2 • 2011   318
would interfere with the release of integrin-associated proteins, 
such as kindlin and talin in focal adhesions and, thereby, would 
reduce the formation or maturation of fibrillar adhesion sites. 
Additional work should be performed to decipher at the molecu-
lar level how 1 integrin participates in focal to fibrillar adhesion 
assembly. But, for the first time, our present work points out the 
importance of integrin cellular adaptors in this process.
Integrin-linked kinase (ILK), PINCH, parvins, and kindlins 
belong to a protein complex that is involved in fibrillar adhesion 
maturation (Vouret-Craviari et al., 2004; Stanchi et al., 2009). 
Loss of kindlins in mice leads to severe phenotypes associated 
with integrin dysfunction in cells (Moser et al., 2008, 2009; Ussar 
et al., 2008). Kindlins bind to the most distal NPxY motif on the 
1 integrin cytoplasmic tail (Meves et al., 2009), where the 
ICAP-1 binding site has also been mapped (Chang et al., 1997). 
Thus, the two proteins would be expected to compete for the 
same overlapping site. This hypothesis is supported by our exper-
iments demonstrating that the loss of ICAP-1 or the expression of 
a 1 integrin mutation within the ICAP-1 binding site increases 
kindlin-2 recruitment on the 1 integrin cytoplasmic domain and 
within focal adhesion sites. ILK, which is recruited at focal adhe-
sion via kindlin-2 in worm and C2C12 cells (Mackinnon et al., 
2002; Dowling et al., 2008), is also involved in fibronectin depo-
sition (Stanchi et al., 2009). Although the interplay among ILK, 
ICAP-1, and kindlin-2 remains to be unraveled, one may now 
place ILK downstream of ICAP-1 as well as kindlin-2.
Fibronectin fibrillogenesis is required for 
osteoblast mineralization
Both the composition and the physical state of the extracellular 
matrix play an important role in controlling osteoblast differen-
tiation and mineralization. For instance, hMSCs cultured on   
a stiff matrix preferentially commit to the osteoblast lineage   
(McBeath et al., 2004; Engler et al., 2006). The extracellular 
matrix can affect osteoblast differentiation both by providing 
specific integrin binding sites and by acting as a reservoir for 
small signaling molecules, such as BMPs or FGFs (Margosio   
et al., 2003; Grünert et al., 2007). Previous studies have estab-
lished the involvement of the extracellular matrix in osteoblast 
differentiation and mineralization (Moursi et al., 1996, 1997). 
Indeed, fibronectin has been shown to be important for osteo-
blast differentiation and survival (Moursi et al., 1996, 1997). 
Our present study not only provides important molecular mech-
anisms explaining these data but also shows the first direct ex-
perimental evidence that fibronectin assembly in itself is crucial 
for mineralization. By modulating 1 integrin translocation into 
fibrillar adhesions, ICAP-1 regulates the amount, the structure, 
and the assembly of matrix-associated fibronectin, which is   
important for the formation of a competent extracellular matrix 
allowing proper mineralization. Our attempts to identify the 
specific  integrin  receptors  involved  in  this  process  by  using 
Figure 9.  Blocking fibronectin fibrillogenesis impairs mineralization.  
(A) Wild-type cells were induced to differentiate into osteoblasts in the 
presence (FUD treated) or absence (control) of FUD, and the expressions of 
alkaline phosphatase (ALP) and mineralization (Alizarin red S [ARS]) were   
monitored at day 0 (D0) and day 14 (D14). (B) Wild-type (1
fl/fl), Icap-1
/, 
and  1
/  cells  were  cultured  as  described  for  in  vitro  mineralization   
assay. At day 0, the medium was changed to induce differentiation. Cells 
were fixed either at day 0 or day 4, and type I collagen deposition was   
analyzed by immunofluorescence staining. (C) Wild-type (1
fl/fl), Icap-1
/, 
and 1
/ cells were embedded in highly concentrated type I collagen 
gel (5 mg/ml). After 1 wk in normal medium to allow cell proliferation, 
the medium was changed for the osteogenic medium, and the culture was 
continued for an additional 21 d. Gels were then stained with Alizarin red S   
to detect mineralized foci. (D) Mineralization of cells expressing high levels 
of kindlin-2 (high) was analyzed after their culture in osteoblast differentia-
tion media. Expression of alkaline phosphatase was used to follow the 
early commitment of cells to the osteoblast lineage at day 3 (D3), and 
mineralization was visualized by Alizarin red S staining at day 15 (D15). 
Bars: (A, C, and D) 1 mm; (B) 20 µm.
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blocking antibodies raised against specific  subunits have 
failed, possibly because of quick endocytosis of the antibodies 
during the course of the experiment (unpublished data). How-
ever, considering the predominant role of the 51 integrin for 
fibronectin fibrillogenesis, it is likely that this integrin is also 
crucial for mineralization. It has been reported that fibronectin 
serves as a scaffolding matrix for additional extracellular pro-
teins, such as collagens and TGF-, but also for sequestering 
and presenting diffusible factors, such as BMPs and FGFs   
(Sottile and Hocking, 2002; Huang et al., 2009; Hynes, 2009). 
Therefore, interfering with fibronectin assembly will affect the 
overall matrix environment, making it less permissive for proper 
mineralization. In line with our present data is the observation 
that the maintenance of an extracellular matrix of fibronectin as 
well as collagen requires continuous fibronectin assembly   
(Sottile and Hocking, 2002; Shi et al., 2010).
Fibronectin is important for  
osteoblast compaction
Osteoblast compaction is an important early step during their 
differentiation (Lecanda et al., 2000). In the absence of efficient 
fibronectin assembly, osteoblast compaction was severely re-
duced. Therefore, Icap-1–deficient osteoblasts that displayed 
reduced fibronectin deposition were unable to properly com-
pact. Similarly, osteoblasts deficient in 1 integrin expression 
had a severe defect in cell compaction. Consistent with our 
findings, fibronectin is important for cell compaction of mesen-
chymal cells, showing that a proper extracellular matrix also 
supports cell compaction in the mesenchymal cell lineage   
(Robinson et al., 2004; Salmenperä et al., 2008). Surprisingly, 
cadherins expressed on osteoblasts (Stains and Civitelli, 2005) 
are not sufficient to support efficient cell compaction in the ab-
sence of 1 integrin even though small cell aggregates were   
observed in 1-null osteoblasts, suggesting that cadherins 
could be involved at earlier stages. More investigations will be   
necessary to address the exact function of cadherins during 
this process.
ROCK has been shown to interact with ICAP-1 (Stroeken 
et al., 2006). In our present work, we did not evidence any linear 
connection between ICAP-1 and ROCK in the regulation of 
cell compaction. Indeed, inhibition of ROCK as well as loss of 
ICAP-1 expression led to cell compaction and the fibronectin 
deposition defect. However, ROCK inhibition in Icap-1–deficient 
cells further reduced cell compaction and fibronectin fibrillo-
genesis, suggesting that both proteins may act through distinct 
signaling pathways. Such ROCK-dependent pathways could be 
activated via the fibronectin receptor syndecan as recently pro-
posed (Wang et al., 2010).
In conclusion, we report a molecular mechanism for the 
osteoblast differentiation defect that is present in Icap-1–deficient 
mice. ICAP-1, likely by interacting directly with 1 integrin, is 
important for translocation of 1 integrins into fibrillar adhe-
sions, which are required for proper fibronectin self-assembly 
into fibrils. Moreover, we show that fibronectin assembly, in 
turn, allows mineralization. Thus, for the first time, we provide 
the mechanism by which ICAP-1 affects bone mineralization at 
a late stage of osteoblast differentiation.
Materials and methods
Mice and antibodies
Mice with a targeted mutation on the Icap-1 locus (Itgb1bp1
tm1Ref) were 
genotyped as previously reported (Bouvard et al., 2007). Mouse strains 
with floxed alleles of the genes encoding 1 integrin (Itgb1
tm1Ref) and fibro-
nectin (Fn1
tm1Ref) have been described previously (Brakebusch et al., 2000; 
Potocnik et al., 2000; Sakai et al., 2001).
Polyclonal  anti–ICAP-1  antibodies  were  described  previously 
(1:1,500; Bouvard et al., 1998). Monoclonal antibodies against actin 
(A2066; 1:1,000), vinculin (clone hVIN1; 1:2,000), and talin (clone 8d4; 
1:200) as well as the polyclonal antibodies against fibronectin (F3648; 
1:1,000) and kindlin-2 (K3269; 1:1,000) were obtained from Sigma-
Aldrich. The polyclonal anti–1 integrin serum was obtained from Millipore 
(1:1,500). The polyclonal anti–1 integrin cytoplasmic domain antibody 
was described previously (Martel et al., 2001). The monoclonal anti–1 
integrin antibodies 9EG7 and MB1.2 were purchased from BD (1:100) 
and Millipore (1:100), respectively. Antiphosphotyrosine monoclonal anti-
body 4G10 used as hybridoma supernatant was produced in our labora-
tory. The monoclonal anti-EGFP antibody (b-2; 1:1,000) was purchased 
from Santa Cruz Biotechnology, Inc.
Plasmids
The 1-expressing construct was based on the pCLMFG retroviral vector, in 
which the wild-type human 1 integrin had been directionally inserted   
using EcoR1 and Not1 sites. D759A and V787T mutations were intro-
duced in 1 integrin by a mutation kit QuikChange; QIAGEN and veri-
fied by sequencing. Expression of mRFP-tensin was performed using the 
pCLMFG-mRFP-tensin plasmid as previously described (Stanchi et al., 
2009). FUD arises from the first fibronectin binding motif of the Streptococ-
cus pyogenes adhesin protein F1. It encompasses the 43 residues of the 
upstream nonrepetitive domain plus the first six residues of the first 37-residue 
repeat of the RD5 region (Tomasini-Johansson et al., 2001). FUD was pro-
duced recombinantly as previously described (Ensenberger et al., 2004). 
pCLMFG-EGFP–kindlin-2 was obtained from R. Fässler (Max Planck Insti-
tute  of  Biochemistry,  Martinsried,  Germany).  cDNA  encoding  the  talin 
head domain was extracted from pBlueScript(SK)-talin (aa 1–1,445; gift 
from R.O. Hynes, Massachusetts Institute of Technology, Cambridge, MA) 
using Spe1 and EcoRV sites and inserted in the pEGFP-N1 plasmid by SalI 
restriction after refilling.
Isolation, immortalization, infection, and in vitro Cre-mediated deletion  
of osteoblasts
A primary mouse osteoblast-enriched cell population was isolated from 
newborn calvaria by using a mixture of 0.3 mg/ml collagenase type I 
(Sigma-Aldrich) and 0.25% trypsin (Invitrogen) as described previously 
(Bellows et al., 1986; Bouvard et al., 2007). Cells were grown in -MEM 
medium containing 10% FCS. Primary osteoblasts (passage 2) were im-
mortalized by transduction with a retrovirus expressing the large SV40   
T antigen (Fässler et al., 1995), cloned, and tested for their ability to induce 
alkaline phosphatase upon differentiation (Mansukhani et al., 2000) as 
previously described (Bouvard et al., 2007). At least five clones from wild-
type or floxed mice were isolated. Rescue of ICAP-1 or 1 integrin ex-
pression in null cells was performed via retroviral infection using the 
pCLMFG-Icap-1-IRES-EGFP and the pCLMFG-1 vectors, respectively, as 
previously described (Bouvard et al., 2007; Millon-Frémillon et al., 2008). 
1- and fibronectin-floxed immortalized osteoblasts were infected with an 
adenoviral  supernatant  encoding  the  Cre  recombinase  (provided  by   
R. Meuwissen, Institut Albert Bonniot, Grenoble, France) for 1 h in PBS sup-
plemented with 2% FCS and 1 mM MgCl2.
Solid-phase assay and pull-down assay
ICAP-1 binding onto the cytoplasmic tail of 1
WT or 1
V787T integrin was 
performed using an enzyme-linked immunosorbent assay. A 96-well tray 
(MaxiSorp; Thermo Fisher Scientific) was coated overnight at 4°C with var-
ious concentrations of His–ICAP-1 (0, 1, and 5 µg/ml) and blocked for 1 h 
at room temperature with a 3% BSA/PBS solution. 5 µg/well GST, 3% BSA 
alone,  or  10  µg/well  GST-tagged  cytoplasmic  1
WT  and  cytoplasmic 
1
V787T  were  incubated  for  1  h  at  37°C.  After  three  washes  with  3% 
BSA/0.01% Tween 20/PBS, the cytoplasmic 1
WT and cytoplasmic 1
V787T 
peptides were detected using a polyclonal antibody against the 1 cyto-
plasmic tail for 45 min at 37°C and an HRP-conjugated secondary anti-
body (Bio-Rad Laboratories) for an additional 45 min at 37°C. Peroxidase 
activity was visualized using ABTS reagent at 405 nm. The efficiency of 
ICAP-1 binding onto cytoplasmic 1
WT or cytoplasmic 1
V787T was ex-
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Mouse primers for fibronectin and collagen I were the following: forward, 
5-ATGTGGACCCCTCCTGATAGT-3, and reverse, 5-GCCCAGTGATTTCA-
GCAAAGG-3; and forward, 5-CCTGGTAAAGATGGGCC-3, and reverse, 
5-CACCAGGTTCACCTTTCGCACC-3, respectively. The level of RNA for 
Icap-1–null cells compared with wild-type cells and normalized to Ranbp1 
was calculated using the comparative cycle threshold method of quantification.
Time-lapse video microscopy
mRFP-tensin–expressing osteoblasts were seeded in complete medium on 
uncoated chambers (Labtek; Thermo Fisher Scientific) and imaged as 
previously described (Millon-Frémillon et al., 2008). In brief, after over-
night spreading, cells were subjected to time-lapse video microscopy 
using a microscope (Axiovert 200M; Carl Zeiss) equipped with a thermo-
static chamber. Images were acquired every 5 min over a 6-h period. Out   
of the stack, three images corresponding to three different time points 
were then selected and overlapped using MetaMorph software (Molecu-
lar Devices) after subtracting cell displacement. The centripetal trans-
location of fibrillar adhesions was shown by arbitrarily coloring each 
time-point image.
FACS, immunohistology, and immunofluorescence
FACS analysis and immunohistology were performed as previously de-
scribed (Bouvard et al., 2007). For immunofluorescence, cells were fixed 
with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100 (this 
step was omitted in the case of fibronectin staining), and incubated with 
appropriate primary antibodies. After being rinsed, coverslips were incu-
bated with an appropriate Alexa Fluor–conjugated secondary antibody. 
The cells were mounted in Mowiol/DAPI solution and imaged on an in-
verted confocal microscope (LSM510; Carl Zeiss).
Online supplemental material
Fig. S1 shows expression and localization of 1 integrins and its mutated 
forms in 1-null osteoblasts. Fig. S2 shows that FUD treatment alters neither 
cell shape nor cell proliferation and survival. Fig. S3 shows that Icap-1
/ 
spheroids exhibit a defect in fibronectin deposition that is not caused by a 
defect in fibronectin and type I collagen expression or fibronectin secretion. 
Fig. S4 shows that 1
V787T integrin mutation interferes with ICAP-1 binding 
but not with kindlin-2 recruitment. Fig. S5 shows a defect in the translocation 
of 1-containing fibrillar adhesion. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201007108/DC1.
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Pull-down assays for talin and kindlin-2 were performed as previ-
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Compaction assay in hanging drops
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pus). When ROCK inhibitor Y27632 (EMD) was used, cells were resus-
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Osteoblast differentiation
In vitro differentiation of isolated osteoblasts was performed essentially as 
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Visualization and quantification of fibronectin deposition and secretion
10
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